Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Gilead Sciences (GILD – Research Report) and keeping the price ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Signaturefd LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.1% in the third ...

Morgan Stanley notes that Gilead (GILD) and Arcellx’s (ACLX) anito-cel, a BCMA-directed CAR-T therapy in development for relapsed / ...

Eisenmenger Complex Management MarketThe global Eisenmenger Complex Management Market is poised for significant growth, projected to exceed USD 12.9 Billion by 2033, up from USD 7.7 Billion in 2023, ...

Catalyst OrthoScience Inc. ("Catalyst"), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced that it has appointed ...

The US Court of Appeals for the Federal Circuit issued its opinion in Allergan USA, Inc. v. MSN Laboratories Private Ltd., No ...

Kusari, a software supply chain security startup, today announced the release of the Kusari Platform. By ingesting Software Bill of Materials (SBOM) data ? a list of all software components ? the ...

The current state of Patent Term Adjustment law often arbitrarily punishes applicants for taking actions that do not actually ...

Eastern Bank purchased a new position in shares of SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY – Free Report) in the 3rd ...

It’s a go for the two phase III Ensure studies of Immunic Inc.’s lead asset in treating relapsing multiple sclerosis. An ...